We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Virtual Model Set to Boost Drug Development Efforts

By LabMedica International staff writers
Posted on 27 Mar 2018
Print article
Image: A novel technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans is based on a microfluidic platform that connects engineered tissues from up to 10 organs (Photo courtesy of Felice Frankel).
Image: A novel technology that could be used to evaluate new drugs and detect possible side effects before the drugs are tested in humans is based on a microfluidic platform that connects engineered tissues from up to 10 organs (Photo courtesy of Felice Frankel).
A novel "physiome-on-a-chip" platform is expected to aid drug developers by combining several "organ-on-a-chip" nodes into an in vitro model of a functioning organism.

Microphysiological systems (MPSs) are in vitro models that capture facets of in vivo organ function through use of specialized culture microenvironments, including three-dimensional matrices and microperfusion. To adapt MPS technology for purposes of drug development, investigators at the Massachusetts Institute of Technology (Cambridge, USA) developed a method to co-culture multiple different MPSs linked together physiologically on re-useable, open-system microfluidic platforms. Each MPS platform represented a different organ and was compatible with the quantitative study of a range of compounds, including lipophilic drugs.

The investigators adapted the physiome-on-a-chip platform from technology they had previously developed and commercialized through the biotechnology company CN BioInnovations (Welwyn Garden City, United Kingdom), The system incorporated several on-board pumps to control the flow of fluids between the "organs," on different nodes replicating the circulation of blood, immune cells, and proteins through the human body.

The investigators reported in the March 14, 2018, online edition of the journal Scientific Reports that they had created several versions of the chip, linking up to 10 organ types: liver, lung, gut, endometrium, brain, heart, pancreas, kidney, skin, and skeletal muscle. Each "organ" consisted of clusters of one million to two million cells.

"Animals do not represent people in all the facets that you need to develop drugs and understand disease," said senior author Dr. Linda Griffith, professor of biological and mechanical engineering at the Massachusetts Institute of Technology. "That is becoming more and more apparent as we look across all kinds of drugs. A lot of the time you do not see problems with a drug, particularly something that might be widely prescribed, until it goes on the market. Some of these effects are really hard to predict from animal models because the situations that lead to them are idiosyncratic. With our chip, you can distribute a drug and then look for the effects on other tissues and measure the exposure and how it is metabolized."

"An advantage of our platform is that we can scale it up or down and accommodate a lot of different configurations," said Dr. Griffith. "I think the field is going to go through a transition where we start to get more information out of a three-organ or four-organ system, and it will start to become cost-competitive because the information you are getting is so much more valuable."

Related Links:
Massachusetts Institute of Technology
CN BioInnovations

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.